A Tier One research university. Tech-driven entrepreneurs and innovators. A burgeoning health district, anchored by a new kind of medical school. These assets and more are turning Austin into a nerve center for innovation in health.
That’s why Wilson Sonsini Goodrich & Rosati — a leading legal advisor to life sciences, technology and other growth enterprises — chose Austin as the location for its Healthcare Innovations Venture Investment Forum, scheduled for Dec. 6-8, 2017, and presented in partnership with Dell Med. The forum brings together investors with innovators, and works to bridge the funding gap that can keep promising research/ideas from becoming products that improve how people get and stay healthy.
Meet With Investors
Startups from across Texas and the country seeking investment will have the opportunity, if selected, to meet privately with one or more investors for 40 minutes. To be considered, companies are invited to register and submit an executive summary and a non-confidential deck by Sept. 15. The deadline for Houston-area startups is Sept. 29 to account for the impact of Hurricane Harvey. Get the details >
As assistant dean for Health Product Innovation at Dell Med, I know our faculty, staff and clinicians are leading projects poised to disrupt the health care industry. This forum is a resource for catalyzing that innovation. And the opportunity isn’t just open to members of the Dell Med community. Researchers from The University of Texas at Austin and Texan entrepreneurs should apply as well.
“At Dell Med, we know health solutions can come from anywhere,” said Mellie Price, the executive director of Commercialization at Dell Med. “Collaborations like this forum are vital to our work — and the work of innovators across the state — in bringing products and services into the market that improve health outcomes and lower costs.”
Sabrina Poulos, a partner based in the Austin office of Wilson Sonsini Goodrich & Rosati, said the firm is looking forward to hosting entrepreneurs at the third Healthcare Innovations Venture Investment Forum.
“We are excited to collaborate with Dell Med to bring top-level investors to Austin to meet with the many entrepreneurs and innovative companies in Texas and across the country that are focused on improving health care,” she said.
Investors participating in the forum include: 3M Ventures, 5AM Ventures, AbbVie Biotech Ventures, Apple Tree Partners, Atlas Venture, ARCH Venture Partners, Bain Capital, Bay City Capital, Deerfield, Gurnet Point Capital, HIG Capital, Illumina Ventures, J&J Innovations, Lilly Ventures, Merck Global Health Innovation Fund, NEA, Novartis Institutes for Biomedical Research, Novo Ventures, Pfizer Inc., RA Capital, Sailing Capital, Siemens Healthineers, SR One, Taiho Ventures, 8VC, Accelerator Corp., Ajax Health, Apex Landmark, Cartmell VC, Charles River Ventures, Civilization Ventures, Hatteras Venture Partners, Integra LifeSciences Holdings, KdT Ventures, Live Oak Venture Partners, Mercury Fund, MP Healthcare Venture Management, PTV Healthcare, S3 Ventures, Santé Ventures, Thiel Capital, Translink Capital Partners and True Wealth Ventures.
Additionally, these companies will review submissions: Asahi Kasei Ventures, Avalon Ventures, Emergent Medical Partners, Foresite Capital, Fortress Biotech, Founders Fund, F-Prime Capital Partners, Frazier Healthcare Partners, GE Ventures, OrbiMed, Pivotal bioVenture Partners, Section 32, TPG Biotech and Versant Ventures.